BSEFabtech Technologies Cleanrooms Ltd· Industrial ManufacturingHighNeutral
Announced Wed, 29 Apr, 2026 · 21:03 IST

Press Release on the Audited Standalone Financial and Consolidated Financials Results of the company for the half year ended and year ended March 31, 2026.

Revenue Growth 20pctEbitda Margin CompressionResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.7%Reaction day
₹293.95
prior close
₹295.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.4%+2.1% vs market
Industrial Products peers, median of 131sector-0.3%+2.1% vs sector

On the reaction day the stock moved 2.1 pts more than Nifty Microcap 250 and 2.1 pts more than its Industrial Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
-1.4
15m
-3.4
30m
-3.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.7-0.4+2.1-0.3+2.1
Next day
+3.4+1.1+2.3+0.4+3.0
2d
+2.1+1.0+1.0+0.5+1.5
3d
+6.8+2.6+4.2+1.0+5.8
4d
+3.8+4.2-0.5+2.3+1.5
5d
+0.7+4.2-3.5+2.4-1.7
1w
-1.3-0.5-0.8-1.5+0.2
15d
+10.2+0.9+9.3-2.9+13.2
1m
+36.1+1.5+34.6-2.8+38.9
2m
+40.5+9.1+31.4+2.5+38.0
3m
+27.6+8.1+19.5+1.3+26.3
UpDownMarket · Nifty Microcap 250Sector · Industrial Products peers, median of 131Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Fabtech Technologies Cleanrooms reported audited consolidated FY2026 revenue of ₹221.72 Crore, up 46.9% from ₹150.89 Crore, crossing the ₹200 Crore milestone. EBITDA grew 28.27% to ₹23.16 Crore, while Profit Before Tax rose 17.14% to ₹19.95 Crore. PAT attributable to shareholders increased 18.95% to ₹15.82 Crore, up from ₹13.29 Crore. PAT margin compressed to 7.13% from 8.81% in FY25, which management attributes to deliberate investments in new sectors (data centres, solar, microelectronics), near-doubling of employee costs to ₹17.7 Crore, and a 143% jump in marketing spend to ₹3.5 Crore. Subsidiaries Kelvin (60.20% stake) and associate AART (28% stake) contributed to growth, with AART's revenue more than doubling. Order book stood at over ₹199 Crore as of March 31, 2026.

Likely market impact

Strong top-line growth signals robust demand and successful sector diversification beyond pharma, but margin compression reflects heavy investment phase. The ₹199 Crore order book and management's 30-40% growth guidance for FY27 provide earnings visibility, though near-term margin recovery remains the key watchpoint for shareholders.